Multiple Sclerosis Therapeutics | Agenda Bookshop Skip to content
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Jeffrey A. Cohen
B01=Richard A. Rudick
Category1=Non-Fiction
Category=MJN
Category=MMZ
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Multiple Sclerosis Therapeutics

English

This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors. See more
Current price €209.94
Original price €220.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Jeffrey A. CohenB01=Richard A. RudickCategory1=Non-FictionCategory=MJNCategory=MMZCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 2400g
  • Dimensions: 225 x 282mm
  • Publication Date: 20 Oct 2011
  • Publisher: Cambridge University Press
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780521766272

About

Jeffrey A. Cohen MD is Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research Department of Neurology Neurological Institute Cleveland Clinic Cleveland OH USA. Richard A. Rudick MD is Director of the Mellen Center for Multiple Sclerosis Treatment and Research Department of Neurology Neurological Institute Cleveland Clinic Cleveland OH USA.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept